Evox Technology

RNA Engineering

Nucleic acid-based therapeutics constitute a core therapeutic modality for Evox’s development programs and we have sophisticated capabilities for loading of primarily RNAs into exosomes. 

RNA loading is done via either proprietary exogenous or endogenous loading methods, which enables Evox to work across both natural and non-natural oligonucleotides. Solving the non-hepatic delivery challenge of nucleic acid-based drugs – such as siRNAs, antisense or even gene editing modalities – is a core mission for Evox and tissue-targeted exosomes represent a very promising technology to achieve this.